⌘K

Login Start Free

Home/Filings/4/0001140361-10-034940

4//SEC Filing

Keese Kyle 4

Accession 0001140361-10-034940

CIK 0001367644other

View on SEC.gov Company Profile

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 1:52 PM ET

Size

6.5 KB

Accession

0001140361-10-034940

Insider Transaction Report

Form 4

Period: 2010-05-27

Emergent BioSolutions Inc.EBS

SVP, Mfg Ops

Transactions

Other
Common Stock
2010-05-27+5,276→ 14,346 total
Sale
Common Stock
2010-08-18$17.50/sh−5,276$92,330→ 9,070 total

Footnotes (1)

[F1]In-kind pro rata distribution from BioPharm, L.L.C., of which the reporting person is a non-managing member, for no consideration.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

Emergent BioSolutions Inc.

CIK 0001367644

Entity typeother

Related Parties

1

filerCIK 0001380186

Filing Metadata

Form type: 4
Filed: Aug 24, 8:00 PM ET
Accepted: Aug 25, 1:52 PM ET
Size: 6.5 KB

View on SEC.gov